Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1800 1
1805 1
1825 1
1889 2
1890 1
1891 1
1893 4
1894 5
1895 3
1896 1
1897 3
1901 1
1902 2
1910 2
1911 3
1912 4
1913 1
1918 1
1943 1
1946 1
1947 4
1949 1
1951 1
1952 1
1953 3
1955 3
1956 3
1957 3
1958 4
1959 3
1960 6
1961 6
1962 2
1963 3
1964 4
1965 8
1966 5
1967 5
1968 5
1969 6
1970 8
1971 12
1972 14
1973 18
1974 8
1975 2
1976 12
1977 5
1978 11
1979 15
1980 16
1981 18
1982 20
1983 9
1984 8
1985 14
1986 11
1987 15
1988 10
1989 16
1990 20
1991 17
1992 24
1993 21
1994 24
1995 30
1996 28
1997 19
1998 35
1999 36
2000 29
2001 31
2002 23
2003 24
2004 27
2005 30
2006 38
2007 37
2008 38
2009 34
2010 47
2011 54
2012 67
2013 52
2014 59
2015 93
2016 89
2017 93
2018 84
2019 43
2020 51
2021 50
2022 58
2023 56
2024 52
2025 22

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,789 results

Results by year

Filters applied: . Clear all
Page 1
Synapse pathology in Alzheimer's disease.
Griffiths J, Grant SGN. Griffiths J, et al. Semin Cell Dev Biol. 2023 Apr;139:13-23. doi: 10.1016/j.semcdb.2022.05.028. Epub 2022 Jun 9. Semin Cell Dev Biol. 2023. PMID: 35690535 Free article. Review.
Tezepelumab in Adults with Uncontrolled Asthma.
Corren J, Parnes JR, Wang L, Mo M, Roseti SL, Griffiths JM, van der Merwe R. Corren J, et al. Among authors: griffiths jm. N Engl J Med. 2017 Sep 7;377(10):936-946. doi: 10.1056/NEJMoa1704064. N Engl J Med. 2017. PMID: 28877011 Free article. Clinical Trial.
A single-cell molecular map of mouse gastrulation and early organogenesis.
Pijuan-Sala B, Griffiths JA, Guibentif C, Hiscock TW, Jawaid W, Calero-Nieto FJ, Mulas C, Ibarra-Soria X, Tyser RCV, Ho DLL, Reik W, Srinivas S, Simons BD, Nichols J, Marioni JC, Göttgens B. Pijuan-Sala B, et al. Among authors: griffiths ja. Nature. 2019 Feb;566(7745):490-495. doi: 10.1038/s41586-019-0933-9. Epub 2019 Feb 20. Nature. 2019. PMID: 30787436 Free PMC article.
Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials.
Corren J, Menzies-Gow A, Chupp G, Israel E, Korn S, Cook B, Ambrose CS, Hellqvist Å, Roseti SL, Molfino NA, Llanos JP, Martin N, Bowen K, Griffiths JM, Parnes JR, Colice G. Corren J, et al. Among authors: griffiths jm. Am J Respir Crit Care Med. 2023 Jul 1;208(1):13-24. doi: 10.1164/rccm.202210-2005OC. Am J Respir Crit Care Med. 2023. PMID: 37015033 Free PMC article. Clinical Trial.
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma.
Menzies-Gow A, Colice G, Griffiths JM, Almqvist G, Ponnarambil S, Kaur P, Ruberto G, Bowen K, Hellqvist Å, Mo M, Garcia Gil E. Menzies-Gow A, et al. Among authors: griffiths jm. Respir Res. 2020 Oct 13;21(1):266. doi: 10.1186/s12931-020-01526-6. Respir Res. 2020. PMID: 33050934 Free PMC article. Clinical Trial.
Toll-like receptor 4 and CD11b expressed on microglia coordinate eradication of Candida albicans cerebral mycosis.
Wu Y, Du S, Bimler LH, Mauk KE, Lortal L, Kichik N, Griffiths JS, Osicka R, Song L, Polsky K, Kasper L, Sebo P, Weatherhead J, Knight JM, Kheradmand F, Zheng H, Richardson JP, Hube B, Naglik JR, Corry DB. Wu Y, et al. Among authors: griffiths js. Cell Rep. 2023 Oct 31;42(10):113240. doi: 10.1016/j.celrep.2023.113240. Epub 2023 Oct 17. Cell Rep. 2023. PMID: 37819761 Free PMC article.
Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study.
Wechsler ME, Menzies-Gow A, Brightling CE, Kuna P, Korn S, Welte T, Griffiths JM, Sałapa K, Hellqvist Å, Almqvist G, Lal H, Kaur P, Skärby T, Colice G; SOURCE study group. Wechsler ME, et al. Among authors: griffiths jm. Lancet Respir Med. 2022 Jul;10(7):650-660. doi: 10.1016/S2213-2600(21)00537-3. Epub 2022 Mar 29. Lancet Respir Med. 2022. PMID: 35364018 Clinical Trial.
Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma (NAVIGATOR).
Pavord ID, Hoyte FCL, Lindsley AW, Ambrose CS, Spahn JD, Roseti SL, Cook B, Griffiths JM, Hellqvist Å, Martin N, Llanos JP, Martin N, Colice G, Corren J. Pavord ID, et al. Among authors: griffiths jm. Ann Allergy Asthma Immunol. 2023 Nov;131(5):587-597.e3. doi: 10.1016/j.anai.2023.08.015. Epub 2023 Aug 23. Ann Allergy Asthma Immunol. 2023. PMID: 37619779 Free article. Clinical Trial.
1,789 results